Effect of recombinant bovine somatotropin and a shortened or no dry period on the performance of lactating dairy cows.
The objective of this study was to determine the effects of altering dry period length in multiparous dairy cows (n = 341) on milk production for a full lactation (294 d). The study used 3 commercial herds in the western United States. Cows producing greater than 8,400 kg of mature-equivalent milk were assigned to treatments 60 d before their due dates. The 4 treatments were 1) 60-d dry period, label use of recombinant bovine somatotropin (rbST; 60d-L); 2) 32-d dry period, label use of rbST (32d-L); 3) 0-d dry period, label use of rbST (0d-L); and 4) 0-d dry period, continuous use of rbST (0d-C). Cows with shortened dry periods produced 625, 1,000, and 1,042 kg of milk during the prepartum period for treatments 2 to 4, respectively. During the postpartum period, cows on the 32d-L treatment produced similar amounts of milk compared with the 60d-L treatment (11,490 vs. 11,968 kg, respectively). However, cows on the 0d-L (10,316 kg) and 0d-C (10,195 kg) treatments produced significantly lower amounts of milk during the postpartum period compared with the 60d-L treatment. Total milk production from the prepartum and postpartum periods was not altered significantly and was 11,974, 12,112, 11,310, and 11,230 kg for treatments 1 to 4, respectively. The concentrations of beta-hydroxybutyrate and nonesterified fatty acids in serum after calving were decreased for cows on the 32d-L, 0d-L, and 0d-C treatments compared with cows on the 60d-L treatment, which may indicate improved metabolic status.
Monsanto Company, LLC, St. Louis, MO 63167, USA. tim.h.klusmeyer@monsanto.com
T H
TH
Klusmeyer
A C
AC
Fitzgerald
A C
AC
Fabellar
J M
JM
Ballam
R A
RA
Cady
J L
JL
Vicini
D000818:Animals; D002417:Cattle / Q000502:physiology*; D003612:Dairying; D005260:Female; D013006:Growth Hormone / Q000494:pharmacology*; D007774:Lactation / Q000187:drug effects* / Q000502:physiology*; D016018:Least-Squares Analysis; D008892:Milk / Q000378:metabolism; D011247:Pregnancy; D011897:Random Allocation; D011994:Recombinant Proteins / Q000494:pharmacology*; D013997:Time Factors
D011994:Recombinant Proteins; D013006:Growth Hormone